GSA Capital Partners’s Encompass Health EHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.8M | Buy |
39,259
+24,906
| +174% | +$2.55M | 0.24% | 35 |
|
|
2025
Q4 | $1.52M | Buy |
14,353
+6,676
| +87% | +$774K | 0.13% | 169 |
|
|
2025
Q3 | $975K | Sell |
7,677
-2,923
| -28% | -$348K | 0.08% | 419 |
|
|
2025
Q2 | $1.3M | Buy |
10,600
+5,031
| +90% | +$575K | 0.09% | 308 |
|
|
2025
Q1 | $564K | Sell |
5,569
-392
| -7% | -$38.3K | 0.05% | 713 |
|
|
2024
Q4 | $550K | Buy |
5,961
+2,436
| +69% | +$239K | 0.04% | 811 |
|
|
2024
Q3 | $341K | Sell |
3,525
-5,703
| -62% | -$512K | 0.03% | 1160 |
|
|
2024
Q2 | $792K | Buy |
9,228
+5,211
| +130% | +$437K | 0.06% | 670 |
|
|
2024
Q1 | $332K | Sell |
4,017
-6,397
| -61% | -$468K | 0.03% | 1152 |
|
|
2023
Q4 | $695K | Sell |
10,414
-9,298
| -47% | -$602K | 0.06% | 596 |
|
|
2023
Q3 | $1.32M | Buy |
+19,712
| New | +$1.36M | 0.11% | 277 |
|
|
2023
Q1 | – | Sell |
-3,399
| Closed | -$203K | – | 1576 |
|
|
2022
Q4 | $203K | Buy |
+3,399
| New | +$185K | 0.03% | 1175 |
|
|
2022
Q1 | – | Sell |
-16,317
| Closed | -$847K | – | 1518 |
|
|
2021
Q4 | $847K | Buy |
16,317
+4,225
| +35% | +$218K | 0.11% | 287 |
|
|
2021
Q3 | $722K | Buy |
12,092
+7,044
| +140% | +$443K | 0.07% | 478 |
|
|
2021
Q2 | $313K | Buy |
+5,048
| New | +$336K | 0.04% | 918 |
|
|
2021
Q1 | – | Sell |
-6,176
| Closed | -$406K | – | 1205 |
|
|
2020
Q4 | $406K | Sell |
6,176
-150
| -2% | -$8.82K | 0.07% | 558 |
|
|
2020
Q3 | $327K | Buy |
+6,326
| New | +$325K | 0.05% | 673 |
|
|
2020
Q2 | – | Sell |
-5,277
| Closed | -$269K | – | 731 |
|
|
2020
Q1 | $269K | Buy |
+5,277
| New | +$304K | 0.07% | 549 |
|
|
2019
Q3 | – | Sell |
-34,924
| Closed | -$1.76M | – | 1473 |
|
|
2019
Q2 | $1.76M | Sell |
34,924
-20,346
| -37% | -$988K | 0.2% | 66 |
|
|
2019
Q1 | $2.57M | Buy |
55,270
+25,414
| +85% | +$1.29M | 0.26% | 40 |
|
|
2018
Q4 | $1.47M | Sell |
29,856
-49,448
| -62% | -$2.81M | 0.17% | 109 |
|
|
2018
Q3 | $4.92M | Buy |
79,304
+74,111
| +1,427% | +$4.51M | 0.27% | 12 |
|
|
2018
Q2 | $280K | Buy |
+5,193
| New | +$260K | 0.01% | 1407 |
|
|
2018
Q1 | – | Sell |
-60,640
| Closed | -$2.38M | – | 1650 |
|
|
2017
Q4 | $2.38M | Buy |
+60,640
| New | +$2.31M | 0.15% | 169 |
|
|
2017
Q3 | – | Sell |
-29,465
| Closed | -$1.14M | – | 1678 |
|
|
2017
Q2 | $1.14M | Buy |
+29,465
| New | +$1.08M | 0.07% | 467 |
|
|
2017
Q1 | – | Sell |
-15,785
| Closed | -$518K | – | 1798 |
|
|
2016
Q4 | $518K | Sell |
15,785
-22,923
| -59% | -$744K | 0.03% | 968 |
|
|
2016
Q3 | $1.25M | Sell |
38,708
-19,617
| -34% | -$636K | 0.07% | 478 |
|
|
2016
Q2 | $1.8M | Buy |
58,325
+26,693
| +84% | +$835K | 0.1% | 287 |
|
|
2016
Q1 | $947K | Sell |
31,632
-4,318
| -12% | -$119K | 0.06% | 580 |
|
|
2015
Q4 | $996K | Buy |
35,950
+440
| +1% | +$12.5K | 0.05% | 710 |
|
|
2015
Q3 | $1.08M | Sell |
35,510
-18,164
| -34% | -$632K | 0.05% | 578 |
|
|
2015
Q2 | $1.97M | Buy |
53,674
+6,851
| +15% | +$244K | 0.08% | 387 |
|
|
2015
Q1 | $1.65M | Sell |
46,823
-10,140
| -18% | -$347K | 0.07% | 467 |
|
|
2014
Q4 | $1.74M | Buy |
56,963
+21,313
| +60% | +$665K | 0.12% | 184 |
|
|
2014
Q3 | $1.05M | Sell |
35,650
-24,044
| -40% | -$733K | 0.06% | 449 |
|
|
2014
Q2 | $1.7M | Buy |
59,694
+47,115
| +375% | +$1.31M | 0.08% | 347 |
|
|
2014
Q1 | $360K | Sell |
12,579
-65,366
| -84% | -$1.7M | 0.03% | 993 |
|
|
2013
Q4 | $2.07M | Buy |
77,945
+63,591
| +443% | +$1.77M | 0.16% | 89 |
|
|
2013
Q3 | $394K | Sell |
14,354
-13,345
| -48% | -$343K | 0.03% | 946 |
|
|
2013
Q2 | $635K | Buy |
+27,699
| New | +$626K | 0.08% | 420 |
|
Other funds holding EHC
VPM
VCM
GSA Capital Partners's EHC Position: Q1 2026 in Review
GSA Capital Partners increased its Encompass Health (EHC) stake by 174% in Q1 2026, buying an estimated $2.55M and bringing the position to 39,259 shares worth $3.8M. The position accounts for 0.24% of the portfolio, ranked #35.
GSA Capital Partners first reported a position in EHC in Q2 2013 and has held it in 40 quarters since. The position peaked at $4.92M in Q3 2018. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.
- GSA Capital Partners held 39,259 shares of Encompass Health worth $3.8M as of Q1 2026.
- GSA Capital Partners bought 24,906 Encompass Health shares in Q1 2026, an estimated $2.55M.
- Encompass Health made up 0.24% of GSA Capital Partners's portfolio in Q1 2026, its #35 holding.
- GSA Capital Partners first reported a position in Encompass Health in Q2 2013 and has held it in 40 quarters since.
- GSA Capital Partners's Encompass Health position peaked at $4.92M in Q3 2018.
- 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.
Based on GSA Capital Partners's 13F filing for Q1 2026, filed 8 May 2026.